Eyegate Pharmaceuticals Inc (NASDAQ:EYEG)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - EYEG

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - EYEG

  • Market Cap$17.260m
  • SymbolNASDAQ:EYEG
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS30233M5031

Company Profile

Eyegate Pharmaceuticals Inc is a US-based clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The company's lead product EGP-437 incorporates a reformulated topically active corticosteroid, Dexamethasone Phosphate, that is delivered into the ocular tissues through a proprietary drug delivery system, the EyeGate II Delivery System. It mainly develops EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and ciliary body.Eyegate Pharmaceuticals Inc focuses on developing and commercializing products for treating diseases and disorders of the eye.

Latest EYEG news

Currently there for this company. Visit our news hub for other news .